IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-06-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1620835114PMID 28584086PMCID PMC5502598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identity

  2021cited by this paper
• Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.

  2016cited by this paper
• Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

  2016cited by this paper
• Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

  2016cited by this paper
• Spontaneous Resolution of Acute Rejection and Tolerance Induction With IL‐2 Fusion Protein in Vascularized Composite Allotransplantation

  2015cited by this paper
• The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

  2015cited by this paper
• Natural Variation in Interleukin-2 Sensitivity Influences Regulatory T-Cell Frequency and Function in Individuals With Long-standing Type 1 Diabetes

  2015cited by this paper
• Natural variation in IL-2 sensitivity influences regulatory T cell frequency and function in individuals with long-standing type 1 diabetes

  2015cited by this paper
• Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity

  2014cited by this paper
• Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

  2014cited by this paper
• Homeostatic control of regulatory T cell diversity

  2014cited by this paper
• Function of a Foxp3 cis-element in protecting regulatory T cell identity.

  2014cited by this paper
• IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.

  2014cited by this paper
• Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients

  2013cited by this paper
• Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

  2013cited by this paper
• CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner

  2013cited by this paper
• Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.

  2013cited by this paper
• Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells

  2012cited by this paper
• CTLA4‐Ig Restores Rejection of MHC Class‐II Mismatched Allografts by Disabling IL‐2‐Expanded Regulatory T Cells

  2012cited by this paper
• Differing Effects of Rapamycin or Calcineurin Inhibitor on T‐Regulatory Cells in Pediatric Liver and Kidney Transplant Recipients

  2012cited by this paper
• Increased CD45RA+FoxP3low Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus

  2012cited by this paper
• The role of interleukin-2 during homeostasis and activation of the immune system

  2012cited by this paper
• Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

  2012cited by this paper
• Constitutive Nuclear Localization of NFAT in Foxp3+ Regulatory T Cells Independent of Calcineurin Activity

  2012cited by this paper
• ICOS-Dependent Homeostasis and Function of Foxp3+ Regulatory T Cells in Islets of Nonobese Diabetic Mice

  2012cited by this paper
• Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.

  2011cited by this paper
• Interleukin-2 and regulatory T cells in graft-versus-host disease.

  2011cited by this paper
• Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

  2010cited by this paper
• FOXP3+ regulatory T cells in the human immune system

  2010cited by this paper
• NFAT pulls the strings during CD4+ T helper cell effector functions.

  2010cited by this paper
• FOXP3 Inhibits Activation-Induced NFAT2 Expression in T Cells Thereby Limiting Effector Cytokine Expression1

  2009cited by this paper
• Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

  2009cited by this paper
• Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25− helper T cells

  2008cited by this paper
• Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

  2008cited by this paper
• Effects of Cyclosporine on Transplant Tolerance: The Role of IL‐2

  2007cited by this paper
• FOXP3 controls regulatory T cell function through cooperation with NFAT.

  2006cited by this paper
• Changes in Tacrolimus Distribution in Blood and Plasma Protein Binding Following Liver Transplantation

  2004cited by this paper
• Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

  1999cited by this paper

• Next steps in regulatory T cells: Biology and clinical application.

  2026cites this paper
• Immunological Crossroads: Optimizing Antirejection Regimens to Sustain Antitumor Immunity in Liver Transplant Recipients with Hepatocellular Carcinoma

  2025cites this paper
• Stem cell activity shapes the pleiotropic effects of IFN-γ and TGF-β in autoimmune diseases, infections, and cancer, and drives autoimmune flares and remissions

  2025cites this paper
• Modified Guilu Erxian Glue regulates Treg immune function to suppress bone marrow failure in aplastic anemia mice

  2025cites this paper
• The Convergence of Curative Strategies: Islet Replacement, Tolerance Induction, and the Path Beyond Immunosuppression in Type 1 Diabetes

  2025cites this paper
• Low-dose post-transplant cyclophosphamide in combination with low-dose alemtuzumab for graft-versus-host-disease prevention in mismatched unrelated allogeneic stem cell transplantation is associated with improved outcomes and reduced toxicity

  2025cites this paper
• Tacrolimus modulates the PI3K AKT mTOR pathway in retinal epithelial cells under inflammatory stress

  2025cites this paper
• Cyanidin-3-O-glucoside-mediated reduction of regulatory T cells: a therapeutic strategy for multiple myeloma

  2025cites this paper
• Comparative Effectiveness of Ustekinumab and Vedolizumab as Maintenance Therapy After Tacrolimus-Induced Improvement in Patients with Acute Severe Ulcerative Colitis: A Retrospective Cohort Study

  2025cites this paper
• Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft

  2025cites this paper
• Tolerogenic Therapies in Cardiac Transplantation

  2025cites this paper
• Cellular interactions in self-directed immune mediated liver diseases.

  2025cites this paper
• The clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation: the LIFT prospective RCT

  2025cites this paper
• Role of FoxP3+ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy

  2024influential citation
• Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression.

  2024cites this paper
• Advancing immunosuppression in liver transplantation: the role of regulatory T cells in immune modulation and graft tolerance

  2024cites this paper
• Chimeric antigen receptor T-cell therapy in autoimmune diseases

  2024cites this paper
• The Critical Role of Regulatory T Cells in Immune Tolerance and Rejection Following Liver Transplantation: Interactions With the Gut Microbiome

  2024cites this paper
• The Number of Episodes of Subtherapeutic Tacrolimus Blood Level Is Independently Associated With Reduced Kidney Graft Survival

  2024cites this paper
• Updates in chronic graft-versus-host disease: novel treatments and best practices in the current era

  2024cites this paper
• De novo design of mini-binder proteins against IL-2 receptor β chain.

  2024cites this paper
• Unlocking Transplant Tolerance with Biomaterials

  2024cites this paper
• Chimeric antigen receptor T cell therapy for autoimmune disease

  2024cites this paper
• New insights in immunomodulation for intestinal transplantation.

  2024cites this paper
• Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

  2024cites this paper
• FOXP3 full length splice variant is associated with kidney allograft tolerance

  2024cites this paper
• A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models

  2024cites this paper
• 他克莫司通过上调脊髓背角AMPA受体的突触表达诱发疼痛

  2024cites this paper
• Low-dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation?

  2024cites this paper
• Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation

  2024cites this paper
• Treg Therapy for the Induction of Immune Tolerance in Transplantation—Not Lost in Translation?

  2023cites this paper
• What happens to regulatory T cells in multiple myeloma

  2023cites this paper
• Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy

  2023cites this paper
• Lower levels of FOXP3 are associated with prolonged inflammatory responses in kidney transplant recipients

  2023cites this paper
• Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance

  2023cites this paper
• Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression

  2023cites this paper
• Interruption of the Intratumor CD8:Treg Crosstalk Improves the Efficacy of PD-1 Immunotherapy

  2023cites this paper
• The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice

  2023cites this paper
• Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives

  2023cites this paper
• Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms.

  2023cites this paper
• Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE

  2023cites this paper
• Low-dose IL-2 promotes immune regulation in face transplantation: A pilot study.

  2023cites this paper
• Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease

  2022cites this paper
• Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus

  2022cites this paper
• Activation of the STAT5 Signaling Pathway by Yiqi Jiedu Formula Induces Regulatory T Cell-Mediated Alleviation of Corneal Immunopathological Damage in Mice With Recurrent Herpes Simplex Keratitis

  2022cites this paper
• Mesenchymal stem cells augment regulatory T cell function via CD80‐mediated interactions and promote allograft survival

  2022cites this paper
• Competitive Binding of Transcription Factors Underlies Flexibility of T Peripheral Helper Cells and T Follicular Helper Cells in SLE.

  2022cites this paper
• Low‐dose IL‐2 prevents murine chronic cardiac allograft rejection: Role for IL‐2‐induced T regulatory cells and exosomes with PD‐L1 and CD73

  2022cites this paper
• Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation

  2022cites this paper
• The trend for transplant medicine development: induction of immune tolerance or regulation of immune response?

  2022cites this paper
• Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients

  2022cites this paper
• The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation

  2022cites this paper
• Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy.

  2022cites this paper
• IL‐2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitor

  2022cites this paper
• P-glycoprotein, FK-binding Protein-12, and the Intracellular Tacrolimus Concentration in T-lymphocytes and Monocytes of Kidney Transplant Recipients

  2022cites this paper
• Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans.

  2022cites this paper
• Translation suppression underlies the restrained COVID-19 mRNA vaccine response in the high-risk immunocompromised group

  2022cites this paper
• IL-2 availability regulates the tissue specific phenotype of murine intra-hepatic Tregs

  2022cites this paper
• Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans

  2022cites this paper
• The potential for Treg-enhancing therapies in transplantation

  2022influential citation
• Immune Suppression in Allogeneic Hematopoietic Stem Cell Transplantation.

  2021cites this paper
• Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis

  2021cites this paper
• Ex vivo delivery of regulatory T-cells for control of alloimmune priming in the donor lung

  2021cites this paper
• Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells

  2021influential citation
• Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway

  2021cites this paper
• Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation

  2021cites this paper
• Peripheral Blood from Rheumatoid Arthritis Patients Shows Decreased Treg CD25 Expression and Reduced Frequency of Effector Treg Subpopulation

  2021cites this paper
• Current Concepts and Advances in Graft-Versus-Host Disease Immunology.

  2021cites this paper
• Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance

  2021cites this paper
• Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease

  2021cites this paper
• Lactobacillus Acidophilus Supplementation Exerts A Synergistic Effect on Tacrolimus Efficacy by Restoring Th17/Treg Imbalance in Lupus-Prone Mice via the SIGNR3 Pathway

  2020cites this paper
• Ex vivo expansion of regulatory T cells from long-term Belatacept-treated kidney transplant patients restores their phenotype and suppressive function but not their FOXP3 TSDR demethylation status.

  2020cites this paper
• Cellular therapies in organ transplantation

  2020cites this paper
• Increased frequency of CD4+CD25highCD127low T cells early after lung transplant is associated with improved graft survival – a retrospective study

  2020cites this paper
• T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation

  2020cites this paper
• Biological drug and drug delivery-mediated immunotherapy

  2020influential citation
• The Human Immune Response to Cadaveric and Living Donor Liver Allografts

  2020cites this paper
• THIRTY YEARS OF TACROLIMUS IN CLINICAL PRACTICE.

  2020cites this paper
• Calcineurin Inhibition Causes α2δ-1–Mediated Tonic Activation of Synaptic NMDA Receptors and Pain Hypersensitivity

  2020cites this paper
• Early reduction of regulatory T cells is associated with acute rejection in liver transplantation under tacrolimus‐based immunosuppression with basiliximab induction

  2020cites this paper
• Mathematical modeling of cancer treatment with radiation and PD-L1 inhibitor

  2020cites this paper
• Recent Advances Show That Abnormal T-Regulatory Cell Function Perpetuates Chronic Inflammatory Arthritis

  2020cites this paper
• IL‐2 therapy preferentially expands adoptively transferred donor‐specific Tregs improving skin allograft survival

  2019cites this paper
• Tipping the Balance.

  2019cites this paper
• Multifunctional nanocarriers for the treatment of periodontitis: Immunomodulatory, antimicrobial, and regenerative strategies.

  2019cites this paper
• Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects

  2019cites this paper
• COPD_A_222195 2697..2709

  2019cites this paper
• Erythromycin Prevents Elastin Peptide-Induced Emphysema and Modulates CD4+T Cell Responses in Mice

  2019cites this paper
• The Role of Regulatory T Cells in Pulmonary Arterial Hypertension

  2019cites this paper
• Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases

  2019cites this paper
• Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects

  2019cites this paper
• Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

  2019cites this paper
• Immunoregulatory role of IL-2/STAT5/CD4+CD25+Foxp3 Treg pathway in the pathogenesis of chronic osteomyelitis.

  2019cites this paper
• Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

  2019cites this paper
• Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis

  2019cites this paper
• Bioprinting an Artificial Pancreas for Type 1 Diabetes

  2019cites this paper
• Interleukin-2/antibody complex expanding Foxp3+ regulatory T cells exacerbates Th2-mediated allergic airway inflammation

  2019cites this paper
• A novel FK506 loaded nanomicelles consisting of amino-terminated poly(ethylene glycol)-block-poly(D,L)-lactic acid and hydroxypropyl methylcellulose for ocular drug delivery.

  2019cites this paper
• Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels

  2019cites this paper
• Different phenotypes of CD4+CD25+Foxp3+ regulatory T cells in recipients post liver transplantation

  2019cites this paper